Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Niclosamide × Gastrointestinal × Clear all
NCT04296851 2020-03-05

Niclosamide for Familial Adenomatous Polyposis

Yonsei University

Phase 2 Unknown
72 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02687009 2020-02-19

A Study of Niclosamide in Patients With Resectable Colon Cancer

Duke University

Phase 1 Terminated
1 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02519582 2018-09-12

Nikolo

Charite University, Berlin, Germany

Phase 2 Unknown
37 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡